Heart failure & cardiomyopathies
Rationale, Design and Baseline Characteristics of a Randomized Controlled Trial of a Cardiovascular Quality Improvement Strategy in India: The Collaborative Quality ImProvement (C-QIP) Trial
Study context
- Population
- Patients with cardiovascular disease (CVD) (ischemic heart disease, ischemic stroke or HF) attending outpatient CVD clinics in India, recruited September 2022 to September 2023
- Participants
- 410 patients · 4 hospitals
- Comparison
- Multicomponent C-QIP intervention vs usual care
- Primary endpoint
- Co-primary: implementation feasibility, fidelity (dose delivered and received), acceptability, adoption and appropriateness, at patient, provider and clinic site level
- Follow-up
- At least 12 months
Methodological detailsrationale, design and baseline characteristics, open, clinic-based, multicentre (4 hospitals), Process and economic evaluations planned, Secondary outcomes: Guideline directed medical therapy (GDMT) prescription (provider level); adherence, change in mean blood pressure (BP) and LDL-C (patient level), Intervention developed through formative research guided by Consolidated Framework for Implementation Research (CFIR)
- Rationale, design and baseline characteristics
- Open
- Clinic-based
- Multicentre (4 hospitals)
- Process and economic evaluations planned
- Secondary outcomes: GDMT prescription (provider level); adherence, change in mean BP and LDL-C (patient level)
- Intervention developed through formative research guided by CFIR
Primary result
As reported in the abstract
Baseline characteristics · baseline
- Age, mean (SD), years
- 57.5 (11.7)
- Males
- 73.0%
- Self-reported hypertension
- 48.5%
- Self-reported diabetes
- 41.5%
- BP, mean (SD), mm Hg
- 127.9 (18.2) /76.2 (11.6)
- LDL-C, mean (SD), mg/dl
- 80.3 (37.3)
- HbA1c, mean (SD)
- 6.8% (1.6%)
- GDMT, ischemic heart disease
- 62.4%
- GDMT, ischemic stroke
- 48.6%
- GDMT, HF
- 36.1%
Original publication
Rationale, Design and Baseline Characteristics of a Randomized Controlled Trial of a Cardiovascular Quality Improvement Strategy in India: The C-QIP Trial. Am Heart J. Published 20 July 2024. doi:10.
Summarised from the published abstract; every number is checked against it